Literature DB >> 7981488

Hepatitis in nursing homes. Incidence and management strategies.

A Floreani1, M Chiaramonte.   

Abstract

Due to improved sanitation and prevention of parenterally transmitted diseases, a trend towards a decreasing incidence of acute viral hepatitis has been observed in several countries in the last years. These changes in epidemiology affect elderly people in different ways, especially if they are residents of homes for the aged. The decrease of hepatitis A virus (HAV) infection in childhood has resulted in less antibody protection during adulthood and old age. This in turn has led to an increased risk of acute and severe hepatitis due to HAV infection, and/or community outbreaks even in elderly people. The spread of parenterally transmitted viruses, such as hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis delta virus (HDV), occurs in homes for the aged, mainly through the common use of toiletries and nondisposable syringes. Improvement in hygiene standards has lead to a marked decrease of these infections. In conclusion, provided that the current hygiene standards are maintained, the risk of parenterally transmitted hepatitis viruses (HBV, HCV and HDV) in homes for the aged will be low. Paradoxically, the risk of enterically transmitted HAV may, in the near future, increase in wealthy institutions and/or in Western countries.

Entities:  

Mesh:

Year:  1994        PMID: 7981488     DOI: 10.2165/00002512-199405020-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  68 in total

1.  Anti-hepatitis C virus in the elderly: a seroepidemiological study in a home for the aged.

Authors:  A Floreani; T Bertin; G Soffiati; R Naccarato; M Chiaramonte
Journal:  Gerontology       Date:  1992       Impact factor: 5.140

2.  Screening before hepatitis A vaccination.

Authors:  P C Turner; R E Eglin; C G Woodward; J Dave
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

3.  Prevalence of anti-HCV antibody in blood donors in the Tokyo area.

Authors:  J Watanabe; K Minegishi; T Mitsumori; M Ishifuji; T Oguchi; M Ueda; E Tokunaga; E Tanaka; K Kiyosawa; S Furuta
Journal:  Vox Sang       Date:  1990       Impact factor: 2.144

4.  Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver).

Authors:  M Chiaramonte; T Stroffolini; N Caporaso; R Coppola; A Craxì; G B Gaeta; E Sagnelli; A R Zanetti
Journal:  Ital J Gastroenterol       Date:  1991-12

5.  The epidemiology of serum hepatitis (SH) infections: a controlled study in two closed institutions.

Authors:  W Szmuness; A M Prince
Journal:  Am J Epidemiol       Date:  1971-12       Impact factor: 4.897

6.  The serum hepatitis virus specific antigen (SH): a preliminary report of epidemiologic studies in an institution for the mentally retarded.

Authors:  W Szmuness; R Pick; A M Prince
Journal:  Am J Epidemiol       Date:  1970-07       Impact factor: 4.897

7.  Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.

Authors:  D K Wong; A M Cheung; K O'Rourke; C D Naylor; A S Detsky; J Heathcote
Journal:  Ann Intern Med       Date:  1993-08-15       Impact factor: 25.391

8.  Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more.

Authors:  D W Scheifele; G J Bjornson
Journal:  CMAJ       Date:  1993-02-15       Impact factor: 8.262

9.  Hepatitis B in a hospital for the mentally subnormal in southern England.

Authors:  J G Kingham; M McGuire; D H Paine; R Wright
Journal:  Br Med J       Date:  1978-08-26

10.  Changing epidemiological characteristics of acute viral hepatitis in Greece.

Authors:  G Papaevangelou; A Roumeliotou-Karayannis; P Contoyannis
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.